Franklin Biotechnology Discv C(acc)USD |
Growth Of 1000 (EUR) | 30/04/2024 |
|
Annual Returns (EUR) | 30/04/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/04 | |
Total Return | 2.14 | -12.60 | 35.20 | 16.33 | -11.60 | -7.32 | 12.68 | 7.32 |
+/- Category | -3.92 | -3.62 | 7.87 | -2.92 | -8.58 | 5.46 | 11.60 | 9.62 |
+/- Category Index | -8.63 | -9.67 | 11.57 | -9.51 | -18.53 | -4.29 | 2.78 | -0.69 |
% Rank in Category | 75 | 82 | 16 | 33 | 79 | 55 | 13 | 5 |
Trailing Returns (EUR) | 01/05/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 2.13 | 1.58 | 1.39 |
1 Week | 3.88 | 2.92 | 2.42 |
1 Month | -3.70 | 1.47 | -2.43 |
3 Months | -0.12 | 2.34 | -4.67 |
6 Months | 27.84 | 25.01 | 10.92 |
YTD | 9.61 | 16.40 | 0.80 |
1 Year | 19.88 | 27.74 | 4.01 |
3 Years Annualised | 1.38 | 4.65 | -6.24 |
5 Years Annualised | 7.17 | 3.73 | -5.18 |
10 Years Annualised | 7.83 | -1.54 | -3.35 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (EUR) | 30/04/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 14.34 | - | - | - |
2023 | -1.27 | 0.77 | 1.18 | 11.93 |
2022 | -7.17 | -5.96 | 8.10 | -1.80 |
2021 | -1.23 | -0.54 | -2.99 | -7.25 |
2020 | -11.21 | 25.55 | -1.30 | 5.72 |
2019 | 20.83 | 1.98 | -10.82 | 23.02 |
Advertisement |